Biggest News Aggregation in the World
๐Ÿ“ฐ Eman Rashed News

Eman Rashed News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Eman Rashed. Real-time updates on events, politics, business and more.

Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis

March 02, 2021 The lower dose of edoxaban (Savaysa; Daiichi-Sankyo) evaluated in ENGAGE AF-TIMI 48 provides a net clinical benefit, according to a new analysis of the trial, suggesting it may be useful for some patients with atrial fibrillation (AF). The trial evaluated two doses of the direct oral anticoagulant (DOAC) versus warfarinโ€”60 and 30 mg once daily; both could be cut in half in patients meeting certain criteria. The rate of a net clinical outcome incorporating stroke/systemic emboli...
New York United States Comunidad Autonoma De Cataluna Jonathan Halperin Eman Rashed Jan Steffel
Source: tctmd.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science